Leone Patterson
Director of Finance/CFO chez TENAYA THERAPEUTICS, INC.
Fortune : 596 823 $ au 29/02/2024
Profil
Currently, Leone D.
Patterson is Chief Financial & Business Officer at Tenaya Therapeutics, Inc. She is also on the board of Oxford Biomedica Plc and Nkarta, Inc.
In her past career Ms. Patterson occupied the position of President, Chief Financial & Accounting Officer at Adverum Biotechnologies, Inc., Chief Financial Officer at Diadexus, Inc., Vice President-Finance for Exelixis, Inc., VP-Global Business Planning & Analysis at Novartis AG and Vice President & Corporate Controller at Chiron Corp.
(a subsidiary of Novartis AG), Vice President & Global Corporate Controller at NetApp, Inc., Chief Financial Officer & Vice President at Transcept Pharma, Inc. and Senior Manager at KPMG LLP.
She received an undergraduate degree from Chapman University and an MBA from St. Mary's College (Indiana).
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
23/02/2024 | 95 755 ( 0,12% ) | 569 742 $ | 29/02/2024 | |
OXFORD BIOMEDICA PLC
0,01% | 26/09/2023 | 12 447 ( 0,01% ) | 27 081 $ | 29/02/2024 |
NKARTA, INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Postes actifs de Leone Patterson
Sociétés | Poste | Début |
---|---|---|
NKARTA, INC. | Director/Board Member | 27/04/2020 |
TENAYA THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2021 |
OXFORD BIOMEDICA PLC | Director/Board Member | 01/05/2023 |
Anciens postes connus de Leone Patterson
Sociétés | Poste | Fin |
---|---|---|
ELIEM THERAPEUTICS, INC. | Director/Board Member | 19/01/2023 |
ADVERUM BIOTECHNOLOGIES, INC. | Chief Executive Officer | 15/06/2020 |
DIADEXUS, INC. | Director of Finance/CFO | 01/06/2016 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Director of Finance/CFO | 30/10/2014 |
NETAPP, INC. | Comptroller/Controller/Auditor | 01/06/2012 |
Formation de Leone Patterson
Chapman University | Undergraduate Degree |
St. Mary's College (Indiana) | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 8 |
---|---|
EXELIXIS, INC. | Health Technology |
NOVARTIS AG | Health Technology |
OXFORD BIOMEDICA PLC | Health Technology |
NETAPP, INC. | Electronic Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
NKARTA, INC. | Health Technology |
TENAYA THERAPEUTICS, INC. | Health Technology |
ELIEM THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
Diadexus, Inc.
Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |